Navigation Links
BioConvergence® Launches New Blog Aimed at Exploring Best Practices of Pharmaceutical and Biotechnology Industries
Date:6/6/2013

Bloomington, Indiana (PRWEB) June 06, 2013

BioConvergence, a contract service provider for pharmaceutical and biotechnology companies, recently launched a life sciences blog that addresses industry best practices.

The blog will cover a wide range of topics including testing and development, quality assurance, production, and supply chain management and security. The breadth of topics is well-suited to the organization, according to Lesli Stasiek, Global Manager of Business Development and Marketing:

“As a contract service provider, we produce unique solutions for life sciences organizations, regardless of their size or product development stage. Beyond this, our team members have gathered to BioConvergence from a wide variety of industry firms of different sizes, and many have worked with contract firms as clients themselves. These factors have given our team a broad perspective of the best practices realm that I know our readership will find both interesting and relevant.”

In addition to the articles supplied by BioConvergence, the company’s alliance partner Modality Solutions will also be contributing regularly.

Modality Solutions employs a Transport Simulation Laboratory of their design to simulate the rigors that pharmaceutical products are exposed to during transportation. BioConvergence then offers the support testing, quality assurance, and storage services needed to accommodate recommendations for formulation improvement.

Modality’s principals add over 100 years of combined life sciences experience to the nearly 500 years represented by the BioConvergence team. BioConvergence hopes that industry professionals, regardless of role, will “take advantage of this resource and gain greater visibility to industry trends and knowledge,” according to Stasiek.

To access BioConvergence’s corporate blog and additional resources, please visit http://blog.bioc.us.

About BioConvergence

BioConvergence is a contract service provider to the life sciences industry, offering outsourcing partnerships for formulation development, testing, production, and supply chain management. A women-owned and operated business headquartered in Bloomington, Indiana, BioConvergence has a team of over 50 members with nearly five centuries’ worth of combined experience in the life sciences industry. The company’s unique E-Transparency® System provides transparency and flexibility to its clients, along with superior, quality-driven outsourcing solutions. For more information, visit http://www.BioC.us.

Read the full story at http://www.prweb.com/releases/2013/6/prweb10807732.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. BioConvergence® Celebrates Seventh Anniversary as a Life Sciences Contract Service Provider
2. BioMedical Life Systems, Inc. Launches New FDA Cleared Non-Prescription TENS Device
3. BellBrook Labs Launches Four New Turn-Key Methyltransferase Assay Kits
4. MAX Launches "Double HELIX" in Marylands Biotechnology Corridor
5. Salimetrics Launches a Faster, More Accurate, Salivary Melatonin Assay
6. Medical Concierge Travel International launches in Tandem with Leading Medical Cost Containment Company, EME International aimed at Self-Funded and Insurance Companies
7. Puritan Medical Products Launches New Series to Tell Customer Stories
8. Dr. Althauser Launches Ground-breaking Cavity Prevention Program That Can Lower Decay Rates by 74%
9. Brookfield Dental Care Launches Ground-breaking Cavity Prevention Program That Can Lower Decay Rates by 74%
10. Elsevier Launches New Open Access Journal: Translational Proteomics
11. Project Oncology CME Series Launches on ReachMD, Offering Learners a Wide Array of Certified Oncology Activities Across an Integrated Platform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... 2016  The Prostate Cancer Foundation (PCF) is pleased to announce ... cures for prostate cancer. Members of the Class of 2016 were selected from ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the sample tracking ... Arkansas State Crime Laboratory, has joined STACS DNA as a Field Application Specialist. ... Jocelyn Tremblay, President and COO of STACS DNA. “In further expanding our capacity as ...
(Date:6/23/2016)... 2016 Andrew D ... http://doi.org/10.17925/OHR.2016.12.01.22 Published recently in ... from touchONCOLOGY, Andrew D Zelenetz , discusses ... care is placing an increasing burden on healthcare ... therapies. With the patents on many biologics expiring, ...
Breaking Biology Technology:
(Date:4/19/2016)... The new GEZE SecuLogic access ... "all-in-one" system solution for all door components. It can ... door interface with integration authorization management system, and thus ... minimal dimensions of the access control and the optimum ... offer considerable freedom of design with regard to the ...
(Date:4/13/2016)... 13, 2016  IMPOWER physicians supporting Medicaid patients in ... new clinical standard in telehealth thanks to a new ... higi platform, IMPOWER patients can routinely track key health ... mass index, and, when they opt in, share them ... to a local retail location at no cost. By ...
(Date:3/23/2016)... 2016 Einzigartige ... und Stimmerkennung mit Passwörtern     ... MESG ), ein führender Anbieter digitaler Kommunikationsdienste, ... SpeechPro zusammenarbeitet, um erstmals dessen Biometrietechnologie einzusetzen. ... Möglichkeit angeboten, im Rahmen mobiler Apps neben ...
Breaking Biology News(10 mins):